Astrocyte activation pathway

The "Astrocyte activation pathway" refers to the ensemble of molecular and cellular mechanisms that regulate the transition of astrocytes from a resting to a reactive state (astrogliosis), typically in response to CNS injury, inflammation, or disease. Activation involves a spectrum of changes including upregulation of intermediate filament proteins (e.g., GFAP, vimentin), altered gene expression (frequently via NF-κB and Nrf2 signaling), variation in cytokine/cytokine receptor interactions, and functional shifts toward neuroprotective or neurotoxic phenotypes. This process is highly context- and stimulus-dependent, underlies both neuroprotective and pathological responses, and is implicated in diverse CNS diseases. The pathway is not a singular drug target; rather, individual components of activation pathways (such as certain enzymes, cytokine receptors, or transcription factors like NF-κB or Nrf2) may serve as specific targets in drug development.

Other names

Astrocyte reactivity pathwayAstrogliosis pathwayAstrocyte activation cascade

Inhibition of astrocyte pro-inflammatory signaling (e.g. NF-κB pathway inhibitors); Modulation of antioxidant responses (e.g. Nrf2 pathway activation); Modulation of neurotransmitter metabolism (e.g. MAO-B inhibition); Blocking cytokine or chemokine signaling